Optum guides members and providers through important upcoming formulary updates. See multiple tabs of linked spreadsheet for Select, Premium & UM Changes.
Close
Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
July 12, 2016 – The FDA announced the approval of Shire’s Xiidra (lifitegrast) for the treatment of the signs and symptoms of dry eye disease (DED).
Download PDF
Return to publications
